Literature DB >> 9525979

Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis.

B M Mueller1, W Ruf.   

Abstract

Tissue factor (TF), the initiating cell surface receptor of the coagulation cascade, plays important roles in embryogenesis, angiogenesis, and tumor cell metastasis. It is controversial whether proteolytic function of TF complexed with its serine protease ligand VIIa is required for metastatic tumor dissemination. We show here in a model for TF-dependent experimental hematogenous metastasis, that TF supports metastasis by both proteolytic activity of the TF-VIIa complex and currently undefined functions of the cytoplasmic domain. We demonstrate that ligand binding of VIIa to TF is required for metastasis. Antimetastatic properties of covalently inactivated VIIa provide evidence that ligand binding is insufficient per se to support metastasis, emphasizing that proteolytic activity is necessary for the metastatic process. Ala or Asp mutations of cytoplasmic serine residues were introduced to preclude or mimic phosphorylation. In vivo analysis of these mutants suggests that local protease generation on the tumor cell surface does not serve simply to activate the cytoplasmic domain of TF by serine phosphorylation. Thus, extracellular functions of the catalytically active TF-VIIa complex cooperate with specific functions of the TF cytoplasmic domain to support the complex process of hematogenous tumor cell dissemination.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525979      PMCID: PMC508714          DOI: 10.1172/JCI930

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

Review 1.  The urokinase receptor: involvement in cell surface proteolysis and cancer invasion.

Authors:  V Ellis; C Pyke; J Eriksen; H Solberg; K Danø
Journal:  Ann N Y Acad Sci       Date:  1992-12-04       Impact factor: 5.691

2.  Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro.

Authors:  A Stahl; B M Mueller
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

3.  Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix.

Authors:  A Klepfish; M A Greco; S Karpatkin
Journal:  Int J Cancer       Date:  1993-04-01       Impact factor: 7.396

4.  Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth.

Authors:  V L Morris; S Koop; I C MacDonald; E E Schmidt; M Grattan; D Percy; A F Chambers; A C Groom
Journal:  Clin Exp Metastasis       Date:  1994-11       Impact factor: 5.150

5.  Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor.

Authors:  C A McNamara; I J Sarembock; L W Gimple; J W Fenton; S R Coughlin; G K Owens
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

6.  Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.

Authors:  B M Mueller; R A Reisfeld; T S Edgington; W Ruf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

7.  Factor VIIa residue Arg290 is required for efficient activation of the macromolecular substrate factor X.

Authors:  W Ruf
Journal:  Biochemistry       Date:  1994-09-27       Impact factor: 3.162

8.  A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production.

Authors:  G Grandaliano; A J Valente; H E Abboud
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

9.  Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion.

Authors:  Y Sugama; C Tiruppathi; K offakidevi; T T Andersen; J W Fenton; A B Malik
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

10.  Thrombin receptor peptide inhibits thrombin-induced increase in endothelial permeability by receptor desensitization.

Authors:  H Lum; T T Andersen; A Siflinger-Birnboim; C Tiruppathi; M S Goligorsky; J W Fenton; A B Malik
Journal:  J Cell Biol       Date:  1993-03       Impact factor: 10.539

View more
  55 in total

1.  Structure of human factor VIIa and its implications for the triggering of blood coagulation.

Authors:  A C Pike; A M Brzozowski; S M Roberts; O H Olsen; E Persson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor.

Authors:  M Riewald; W Ruf
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  Factor VII deficiency impairs cutaneous wound healing in mice.

Authors:  Zhi Xu; Haifeng Xu; Victoria A Ploplis; Francis J Castellino
Journal:  Mol Med       Date:  2010-02-11       Impact factor: 6.354

4.  Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion.

Authors:  S D Konduri; A Tasiou; N Chandrasekar; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Contributions of thrombin targets to tissue factor-dependent metastasis in hyperthrombotic mice.

Authors:  N Yokota; A Zarpellon; S Chakrabarty; V Y Bogdanov; A Gruber; F J Castellino; N Mackman; L G Ellies; H Weiler; Z M Ruggeri; W Ruf
Journal:  J Thromb Haemost       Date:  2014-01       Impact factor: 5.824

Review 6.  Tissue factor and PAR2 signaling in the tumor microenvironment.

Authors:  Florence Schaffner; Wolfram Ruf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-06       Impact factor: 8.311

7.  In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2.

Authors:  S S Lakka; S D Konduri; S Mohanam; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

8.  Cross-talk of integrin alpha3beta1 and tissue factor in cell migration.

Authors:  Andrea Dorfleutner; Edith Hintermann; Takehiko Tarui; Yoshikazu Takada; Wolfram Ruf
Journal:  Mol Biol Cell       Date:  2004-07-14       Impact factor: 4.138

9.  Endothelial cell protein C receptor opposes mesothelioma growth driven by tissue factor.

Authors:  Shiva Keshava; Sanghamitra Sahoo; Torry A Tucker; Steven Idell; L Vijaya Mohan Rao; Usha R Pendurthi
Journal:  Cancer Res       Date:  2013-03-28       Impact factor: 12.701

10.  Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.

Authors:  Gertrud M Hjortoe; Lars C Petersen; Tatjana Albrektsen; Brit B Sorensen; Peder L Norby; Samir K Mandal; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2004-01-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.